Warning: The NCBI web site requires JavaScript to function. more...
Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation.
Pizzey R, Hunt N.
Harm Reduct J. 2008 Jul 21;5:24.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
A rapid assessment of heroin use in Mombasa, Kenya.
Beckerleg S, Telfer M, Sadiq A.
Subst Use Misuse. 2006;41(6-7):1029-44.
Syringe exchanges: a public health response to problem drug use.
Cox GM, Lawless MC, Cassin SP, Geoghegan TW.
Ir Med J. 2000 Jul-Aug;93(5):143-6.
The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort study in Cheshire and Merseyside, UK.
Beynon CM, McVeigh J, Chandler M, Wareing M, Bellis MA.
Harm Reduct J. 2007 Dec 11;4:21.
Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C, Conroy E, Lowe J, Page J, Dolan K.
Aust J Rural Health. 2006 Jun;14(3):120-5.
Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.
Islam M, Stern T, Conigrave KM, Wodak A.
Drug Alcohol Rev. 2008 Jan;27(1):13-9.
Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
Gossop M, Stewart D, Marsden J, Kidd T, Strang J.
Addict Behav. 2004 Aug;29(6):1085-94.
Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey.
Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L; Collaboration of Australian Needle Syringe Programs.
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):632-8.
Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?
Brener L, Spooner C, Treloar C.
Int J Drug Policy. 2010 May;21(3):160-4. Epub 2009 May 7.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.
Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, des Jarlais DC.
Addiction. 2001 Jun;96(6):847-60.
Drug use and HIV/AIDS in China.
Liu Z, Lian Z, Zhao C.
Drug Alcohol Rev. 2006 Mar;25(2):173-5. Review.
Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK.
Maliphant J, Scott J.
Harm Reduct J. 2005 Apr 15;2(1):6.
An evaluation of a heroin overdose prevention and education campaign.
Horyniak D, Higgs P, Lewis J, Winter R, Dietze P, Aitken C.
Drug Alcohol Rev. 2010 Jan;29(1):5-11.
Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
De P, Jolly A, Cox J, Boivin JF.
Can J Public Health. 2006 May-Jun;97(3):207-9.
Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors.
Griffiths P, Gossop M, Powis B, Strang J.
Addiction. 1994 Mar;89(3):301-9.
How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples.
Strang J, Griffiths P, Powis B, Abbey J, Gossop M.
Drug Alcohol Depend. 1997 Jun 6;46(1-2):115-8.
Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
Healey A, Knapp M, Marsden J, Gossop M, Stewart D.
J Health Serv Res Policy. 2003 Jul;8(3):134-41.
Heroin chasers and heroin injectors: differences observed in a community sample in London, UK.
Strang J, Griffiths P, Powis B, Gossop M.
Am J Addict. 1999 Spring;8(2):148-60.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on